SCHEMBL27913629

SCHEMBL27913629

CC(C)(C)NCc1cccc(C(F)(F)F)c1F.NC(=O)c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CD38 P28907 3/20 0.47
MAOB P27338 1/20 0.44
P2RX7 Q99572 8/20 0.43
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39
AURKB Q96GD4 1/20 0.39
ANO1 Q5XXA6 1/20 0.38
CYP3A4 P08684 1/20 0.37
PLOD2 O00469 1/20 0.37
PLOD3 O60568 1/20 0.37
PLOD1 Q02809 1/20 0.37
NTRK1 P04629 1/20 0.37
VNN1 O95497 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
NR3C2 P08235 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27913934 0.88 P2RX7 (0.47) MAOBP2RX7
SCHEMBL28093891 0.87 CD38 (0.51) CD38MAOBP2RX7AURKARPS6KB1
SCHEMBL27931758 0.84 HDAC3 (0.40) P2RX7NTRK1HDAC3HDAC1HDAC2
Pyrazinamide SCHEMBL28093544 0.84 CD38 (0.45) CD38P2RX7ANO1CYP3A4
SCHEMBL15432484 0.81 P2RX7 (0.44) CD38P2RX7
SCHEMBL27913635 0.78 KMT2A (0.56) P2RX7
SCHEMBL27913577 0.77 VNN1 (0.53) P2RX7AURKARPS6KB1AURKBVNN1
SCHEMBL27931776 0.77 VNN1 (0.46) MAOBP2RX7AURKARPS6KB1AURKB
SCHEMBL27913547 0.77 JAK2 (0.42) MAOBANO1VNN1
SCHEMBL27913648 0.74 AURKA (0.53) P2RX7AURKARPS6KB1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103249721-A Arylamine Derivatives as TTX-S Blockers RAQUALIA PHARMA INC 2013-08-14 CN claimed
CN-103249721-A Arylamine Derivatives as TTX-S Blockers RAQUALIA PHARMA INC 2013-08-14 CN disclosed